Package 57844-110-01

{"route": ["ORAL"], "spl_id": "79af1dc6-c7cf-41b1-a750-e9b47c2187ff", "openfda": {"unii": ["O1ZPV620O4", "6DPV8NK46S", "G83415V073", "JJ768O327N"], "rxcui": ["541363", "541365", "541878", "541879", "541892", "541894", "577957", "577960", "577961", "577962", "687043", "687045", "1009145", "1009147"], "spl_set_id": ["f22635fe-821d-4cde-aa12-419f8b53db81"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (57844-110-01)", "package_ndc": "57844-110-01", "marketing_start_date": "20140203"}], "brand_name": "Adderall", "product_id": "57844-110_79af1dc6-c7cf-41b1-a750-e9b47c2187ff", "dosage_form": "TABLET", "pharm_class": ["Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Central Nervous System Stimulation [PE]", "Central Nervous System Stimulation [PE]", "Central Nervous System Stimulation [PE]"], "product_ndc": "57844-110", "dea_schedule": "CII", "generic_name": "Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate", "labeler_name": "Teva Pharmaceuticals USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Adderall", "active_ingredients": [{"name": "AMPHETAMINE ASPARTATE MONOHYDRATE", "strength": "2.5 mg/1"}, {"name": "AMPHETAMINE SULFATE", "strength": "2.5 mg/1"}, {"name": "DEXTROAMPHETAMINE SACCHARATE", "strength": "2.5 mg/1"}, {"name": "DEXTROAMPHETAMINE SULFATE", "strength": "2.5 mg/1"}], "application_number": "ANDA040422", "marketing_category": "ANDA", "marketing_start_date": "20140203", "listing_expiration_date": "20261231"}